David Shaw’s Molina Healthcare MOH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.6M Buy
208,027
+125,544
+152% +$22.8M 0.02% 791
2026
Q1
$11M Sell
82,483
-304,635
-79% -$48.5M 0.01% 1551
2025
Q4
$67.2M Buy
387,118
+142,067
+58% +$23.4M 0.04% 570
2025
Q3
$46.9M Buy
245,051
+115,433
+89% +$21.2M 0.03% 690
2025
Q2
$38.6M Sell
129,618
-61,711
-32% -$19.4M 0.03% 687
2025
Q1
$63M Sell
191,329
-27,550
-13% -$8.32M 0.06% 407
2024
Q4
$63.7M Buy
218,879
+156,278
+250% +$48.3M 0.05% 467
2024
Q3
$21.6M Buy
62,601
+31,278
+100% +$10.3M 0.02% 956
2024
Q2
$9.31M Buy
31,323
+16,252
+108% +$5.52M 0.01% 1381
2024
Q1
$6.19M Buy
15,071
+12,522
+491% +$4.85M 0.01% 1725
2023
Q4
$921K Sell
2,549
-3,160
-55% -$1.11M ﹤0.01% 3187
2023
Q3
$1.87M Sell
5,709
-5,856
-51% -$1.84M ﹤0.01% 2620
2023
Q2
$3.48M Sell
11,565
-278
-2% -$79.9K ﹤0.01% 2158
2023
Q1
$3.17M Buy
11,843
+7,618
+180% +$2.19M ﹤0.01% 2334
2022
Q4
$1.4M Buy
4,225
+1,150
+37% +$391K ﹤0.01% 3213
2022
Q3
$1.01M Sell
3,075
-12,837
-81% -$4.13M ﹤0.01% 3583
2022
Q2
$4.45M Sell
15,912
-22,228
-58% -$6.72M 0.01% 2271
2022
Q1
$12.7M Sell
38,140
-63,768
-63% -$19.6M 0.01% 1385
2021
Q4
$32.4M Sell
101,908
-27,331
-21% -$8.13M 0.03% 779
2021
Q3
$35.1M Sell
129,239
-37,409
-22% -$9.88M 0.03% 700
2021
Q2
$42.2M Sell
166,648
-18,336
-10% -$4.61M 0.04% 631
2021
Q1
$43.2M Buy
184,984
+59,038
+47% +$13.2M 0.04% 555
2020
Q4
$26.8M Sell
125,946
-34,445
-21% -$7.11M 0.02% 814
2020
Q3
$29.4M Sell
160,391
-42,432
-21% -$7.72M 0.03% 645
2020
Q2
$36.1M Sell
202,823
-134,985
-40% -$23M 0.04% 495
2020
Q1
$47.2M Buy
337,808
+76,804
+29% +$10.3M 0.07% 298
2019
Q4
$35.4M Buy
261,004
+6,562
+3% +$827K 0.04% 538
2019
Q3
$27.9M Buy
254,442
+22,873
+10% +$2.96M 0.03% 617
2019
Q2
$33.1M Sell
231,569
-103,373
-31% -$14.2M 0.04% 513
2019
Q1
$47.5M Sell
334,942
-183,581
-35% -$24.8M 0.06% 397
2018
Q4
$60.3M Buy
518,523
+79,013
+18% +$10.4M 0.08% 289
2018
Q3
$65.4M Buy
439,510
+5,403
+1% +$690K 0.08% 308
2018
Q2
$42.5M Buy
434,107
+261,404
+151% +$22.8M 0.06% 414
2018
Q1
$14M Buy
172,703
+11,080
+7% +$891K 0.02% 819
2017
Q4
$12.4M Buy
161,623
+89,067
+123% +$6.43M 0.02% 909
2017
Q3
$4.99M Buy
+72,556
New +$4.72M 0.01% 1377
2017
Q2
Sell
-224,189
Closed -$10.2M 3478
2017
Q1
$10.2M Sell
224,189
-29,009
-11% -$1.52M 0.02% 870
2016
Q4
$13.7M Buy
253,198
+72,184
+40% +$3.95M 0.02% 787
2016
Q3
$10.6M Buy
181,014
+156,223
+630% +$8.61M 0.02% 856
2016
Q2
$1.24M Buy
+24,791
New +$1.33M ﹤0.01% 2279
2016
Q1
Sell
-20,815
Closed -$1.25M 3642
2015
Q4
$1.25M Buy
20,815
+15,215
+272% +$959K ﹤0.01% 2490
2015
Q3
$386K Buy
+5,600
New +$415K ﹤0.01% 3226
2014
Q3
Sell
-13,265
Closed -$592K 4283
2014
Q2
$592K Sell
13,265
-14,388
-52% -$583K ﹤0.01% 3393
2014
Q1
$1.04M Sell
27,653
-35,110
-56% -$1.29M ﹤0.01% 2995
2013
Q4
$2.18M Sell
62,763
-109,980
-64% -$3.71M ﹤0.01% 2448
2013
Q3
$6.15M Buy
172,743
+161,143
+1,389% +$5.95M 0.01% 1404
2013
Q2
$431K Buy
+11,600
New +$410K ﹤0.01% 3351

Other funds holding MOH

David Shaw's MOH Position: Q2 2026 in Review

David Shaw increased its Molina Healthcare (MOH) stake by 152% in Q2 2026, buying an estimated $22.8M and bringing the position to 208,027 shares worth $47.6M. The position accounts for 0.02% of the portfolio, ranked #791.

David Shaw first reported a position in MOH in Q2 2013 and has held it in 47 quarters since. The position peaked at $67.2M in Q4 2025. 597 funds tracked by Wall St. Rank hold MOH as of Q2 2026.

  • David Shaw held 208,027 shares of Molina Healthcare worth $47.6M as of Q2 2026.
  • David Shaw bought 125,544 Molina Healthcare shares in Q2 2026, an estimated $22.8M.
  • Molina Healthcare made up 0.02% of David Shaw's portfolio in Q2 2026, its #791 holding.
  • David Shaw first reported a position in Molina Healthcare in Q2 2013 and has held it in 47 quarters since.
  • David Shaw's Molina Healthcare position peaked at $67.2M in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Molina Healthcare as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.